The Göttingen Minipig (GöMP), resulting from intentional crossbreeding at the University of Göttingen in the 1960s, has become a cornerstone in toxicological testing and pharmacological research for over four decades. Known for its small size, calm demeanor, and efficient reproduction, this breed, a combination of the Minnesota Minipig, Vietnamese Potbelly Pig, and German Landrace, provides researchers with a convenient model for in vivo experiments. Their compact size saves space and feed, while their gentle nature simplifies handling. Meticulously maintained health records further enhance their usefulness in pharmaceutical studies. GöMPs are increasingly favored for research on various diseases like arthritis, cardiovascular diseases, and Parkinson’s disease, aiding in significant medical advancements.

GöMP Peripheral Blood Mononuclear Cells (PBMCs) are valuable resources in immunological research and drug development. Isolated from these miniature pigs, PBMCs offer a unique model for studying immune responses, vaccine development, and immunotherapy. With their genetic stability and well-documented health records, GöMP PBMCs provide a reliable platform for investigating autoimmune disorders, infectious diseases, and cancer. Additionally, their ease of handling and availability in large uniform groups make them practical for in vitro experiments. Overall, GöMP PBMCs represent a promising tool for advancing our understanding of immune function and developing novel therapeutics.